Ananda Ghosh
Stock Analyst at H.C. Wainwright
(4.59)
# 950
Out of 4,792 analysts
120
Total ratings
54.9%
Success rate
22.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ananda Ghosh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GPCR Structure Therapeutics | Reiterated: Buy | $70 | $39.55 | +76.99% | 21 | Sep 9, 2026 | |
| PEPG PepGen | Reiterated: Buy | $20 | $3.02 | +562.25% | 14 | Sep 9, 2026 | |
| ACAD ACADIA Pharmaceuticals | Reiterated: Buy | $37 | $27.74 | +33.38% | 14 | Aug 25, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $50 | $18.42 | +171.44% | 10 | Aug 17, 2026 | |
| PRQR ProQR Therapeutics | Reiterated: Buy | $12 | $1.94 | +518.56% | 10 | Aug 17, 2026 | |
| ANNX Annexon | Reiterated: Buy | $14 | $4.14 | +238.16% | 9 | Aug 14, 2026 | |
| MAZE Maze Therapeutics | Reiterated: Buy | $110 | $24.82 | +343.19% | 20 | Aug 12, 2026 | |
| STOK Stoke Therapeutics | Reiterated: Buy | $50 | $29.34 | +70.42% | 11 | Aug 4, 2026 | |
| SKYE Skye Bioscience | Reiterated: Buy | $160 | $2.08 | +7,592.31% | 7 | May 21, 2026 | |
| IVA Inventiva | Reiterated: Buy | $24 | $4.14 | +479.71% | 4 | Jan 28, 2026 |
Structure Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $70
Current: $39.55
Upside: +76.99%
PepGen
Sep 9, 2026
Reiterated: Buy
Price Target: $20
Current: $3.02
Upside: +562.25%
ACADIA Pharmaceuticals
Aug 25, 2026
Reiterated: Buy
Price Target: $37
Current: $27.74
Upside: +33.38%
Dyne Therapeutics
Aug 17, 2026
Reiterated: Buy
Price Target: $50
Current: $18.42
Upside: +171.44%
ProQR Therapeutics
Aug 17, 2026
Reiterated: Buy
Price Target: $12
Current: $1.94
Upside: +518.56%
Annexon
Aug 14, 2026
Reiterated: Buy
Price Target: $14
Current: $4.14
Upside: +238.16%
Maze Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $110
Current: $24.82
Upside: +343.19%
Stoke Therapeutics
Aug 4, 2026
Reiterated: Buy
Price Target: $50
Current: $29.34
Upside: +70.42%
Skye Bioscience
May 21, 2026
Reiterated: Buy
Price Target: $160
Current: $2.08
Upside: +7,592.31%
Inventiva
Jan 28, 2026
Reiterated: Buy
Price Target: $24
Current: $4.14
Upside: +479.71%